Gary G Koch

发表

Flexible Analytical Methods for Adding a Treatment Arm Mid-Study to an Ongoing Clinical Trial

Wenle Zhao, Yuko Y Palesch, Jordan J Elm, 2012, Journal of biopharmaceutical statistics.

Genetic association analysis under complex survey sampling: the Hispanic Community Health Study/Study of Latinos.

Ran Tao, Donglin Zeng, Dan-Yu Lin, 2014, American journal of human genetics.

On model selections for repeated measurement data in clinical studies

Bo Jin, Haibo Zhou, Gary G Koch, 2015, Statistics in medicine.

A model‐based conditional power assessment for decision making in randomized controlled trial studies

Fei Zou, Jianwen Cai, Haibo Zhou, 2017, Statistics in medicine.

Methods for clarifying criteria for study continuation at interim analysis.

Anastasia Ivanova, Gary G Koch, Laura E Wiener, 2020, Pharmaceutical statistics.

On kernel machine learning for propensity score estimation under complex confounding structures

Fei Zou, Gary G Koch, Baiming Zou, 2021, Pharmaceutical statistics.

Innovative strategies using SUDAAN for analysis of health surveys with complex samples

Lisa M LaVange, Gary G Koch, G. Koch, 1996, Statistical methods in medical research.

Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies.

Lisa M LaVange, Gary G Koch, G. Koch, 2003, Schizophrenia bulletin.

REVIEW AND EVALUATION OF METHODS FOR COMPUTING CONFIDENCE INTERVALS FOR THE RATIO OF TWO PROPORTIONS AND CONSIDERATIONS FOR NON-INFERIORITY CLINICAL TRIALS

Gary G Koch, G. Koch, Rebekkah S. Dann, 2004, Journal of biopharmaceutical statistics.

Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.

Gary G Koch, G. Koch, T. Pincus, 2005, Arthritis and rheumatism.

A non‐parametric procedure for evaluating treatment effect in the meta‐analysis of survival data

Gary G Koch, G. Koch, Patricia F Moodie, 2004, Statistics in medicine.

A Multiple Imputation Method for Sensitivity Analyses of Time-to-Event Data with Possibly Informative Censoring

Haibo Zhou, Amy H Herring, Gary G Koch, 2014, Journal of biopharmaceutical statistics.

A Modified X 2 Approach for Fitting Weibull Models to Synthetic Life Tables a Modified X 2 Approach for Fitting Weibull Models to Synthetic Life Tables

Gary G Koch, G. Koch, D. H. Freeman, 2022 .

Applications of Extensions of Bivariate Rank Sum Statistics to the Crossover Design to Compare Two Treatments Through Four Sequence Groups

Atsushi Kawaguchi, Gary G Koch, G. Koch, 2009, Biometrics.

Type I Error and Power in Noninferiority/Equivalence Trials with Correlated Multiple Endpoints: An Example from Vaccine Development Trials

Gary G Koch, G. Koch, L. Kong, 2004, Journal of biopharmaceutical statistics.

Time to All-Cause Treatment Discontinuation as the Primary Outcome in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Study

Jeffrey A Lieberman, Gary G Koch, Robert A Rosenheck, 2011, Statistics in biopharmaceutical research.

Rank Score Tests

Lisa M LaVange, Gary G Koch, G. Koch, 2006, Circulation.

Randomization-based nonparametric methods for the analysis of multicentre trials

Lisa M LaVange, Gary G Koch, Todd A. Durham, 2005, Statistical methods in medical research.